These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18246694)

  • 1. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses.
    Gold MH
    J Drugs Dermatol; 2008 Jan; 7(1):23-5. PubMed ID: 18246694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system.
    Colombo GL; Chimenti S; Di Matteo S; Fargnoli MC; Frascione P; Silipo V; Peris K
    G Ital Dermatol Venereol; 2010 Oct; 145(5):573-81. PubMed ID: 20930692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for actinic keratoses.
    Gupta AK; Paquet M; Villanueva E; Brintnell W
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004415. PubMed ID: 23235610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
    Gupta AK; Paquet M
    Br J Dermatol; 2013 Aug; 169(2):250-9. PubMed ID: 23550994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational Study.
    van Rijsingen MC; Seubring I; Grutters JP; Maessen-Visch MB; Alkemade HA; van Doorn R; Groenewoud H; van de Kerkhof PC; van der Wilt GJ; Gerritsen MJ
    Acta Derm Venereol; 2016 Mar; 96(3):346-50. PubMed ID: 26280988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatments of actinic keratosis.
    Gold MH; Nestor MS
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
    Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.
    Wilson EC
    Pharmacoeconomics; 2010; 28(11):1055-64. PubMed ID: 20936887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and novel treatment options for actinic keratosis.
    Jorizzo JL
    J Cutan Med Surg; 2004; 8 Suppl 3():13-21. PubMed ID: 15647860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses.
    Hadley J; Tristani-Firouzi P; Hull C; Florell S; Cotter M; Hadley M
    Dermatol Surg; 2012 May; 38(5):722-7. PubMed ID: 22340282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of topical treatments for actinic keratosis.
    Muston D; Downs A; Rives V
    J Dermatolog Treat; 2009; 20(5):266-75. PubMed ID: 19421918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy.
    Pei S; Kaminska ECN; Tsoukas MM
    Dermatol Surg; 2017 Sep; 43(9):1170-1175. PubMed ID: 28562434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
    Van der Geer S; Krekels GA
    J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis.
    Tanghetti EA; Hamann C; Tanghetti M
    J Drugs Dermatol; 2015 Nov; 14(11):1241-4. PubMed ID: 26580872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
    Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
    Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Schmitt AR; Bordeaux JS
    Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
    Samrao A; Cockerell CJ
    Am J Clin Dermatol; 2013 Aug; 14(4):273-7. PubMed ID: 23640424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional treatment of actinic keratosis: an overview.
    Peris K; Fargnoli MC
    Curr Probl Dermatol; 2015; 46():108-14. PubMed ID: 25561214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis.
    Nisticò S; Del Duca E; Torchia V; Gliozzi M; Bottoni U; Muscoli C
    Int J Immunopathol Pharmacol; 2018; 32():2058738418757925. PubMed ID: 29442526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.